Clinical Trial Update: Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compared two dosages of low-molecular-weight heparin in cancer patients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Cancer | Phase 3 | Status: COMPLETED